P
Pinshan Biotechnology
Biopharmaceutical consumables for filtration and chromatography processes.
About Pinshan Biotechnology
Pinshan Biotechnology (Shanghai) Co., Ltd. is a company established in 2021 that specializes in the research, development, production, and sale of core consumables for the biopharmaceutical industry. The company aims to support the localization of biopharmaceutical process consumables in China, reducing reliance on imported technologies. Pinshan Biotechnology's Chairman and General Manager is Han Han.The company's business model is focused on providing comprehensive solutions and products for key bioprocess stages, including cell culture, filtration, separation, and purification. Its client base consists of global biopharmaceutical enterprises engaged in areas such as antibody drugs, gene therapy, and cellular immunotherapy. Pinshan operates several production bases and R&D centers in Shanghai and its surrounding areas, which are managed according to GMP standards and have received ISO9001 quality management system certification.Pinshan's product portfolio includes high-end filtration membranes and chromatography fillers. Key product lines are CulClear® Depth Filters, HiFTra™ PEI Transfection Reagents, and various chromatography solutions based on hydroxyapatite, agarose, and polymer matrices. The HiFTra™ PEI transfection reagent has received a US FDA Drug Master File (DMF) filing. In July 2026, the company announced the completion of a Series A financing round of nearly 100 million RMB to support R&D, industrialization of core products, and commercial expansion.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jul 2026 | $14M | $55M | Xunshang Venture Capital · Ruixia Investment · Yifeng Capital | ↗ |
Growth signals
Latest recorded traffic for Pinshan Biotechnology is 3K monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Pinshan Biotechnology in its local ecosystem
The Pinshan Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- YCYifeng Capital
- XCXunshang Venture Capital
- RIRuixia Investment
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pinshan Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pinshan Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









